The characterization, stabilization, and formulation of acidic fibroblast growth factor.
Volkin
D B
DB
Department of Vaccine Pharmaceutical Research, Merck Research Laboratories, West Point, Pennsylvania 19486, USA.
Middaugh
C R
CR
D000818:Animals; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D004355:Drug Stability; D016220:Fibroblast Growth Factor 1 / Q000008:administration & dosage / Q000737:chemistry* / Q000494:pharmacology; D006801:Humans; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology; D014945:Wound Healing / Q000187:drug effects
D011994:Recombinant Proteins; D016220:Fibroblast Growth Factor 1